Some tumorigenic FTO SNPs were reported to be BMI-related [75,77,79] while others were independent of BMI [74,78,80,81]; indicating that obesity may confer increased risk in some cancers, through a potentially common FTO metabolic-tumorigenic regulatory axis. Here, FTO is linked to obesity due to melanocortin 4 receptor deficiency.